Literature DB >> 21307191

Both nonstructural proteins NS1 and NS2 of pneumonia virus of mice are inhibitors of the interferon type I and type III responses in vivo.

Britta Heinze1, Stefanie Frey, Markus Mordstein, Anette Schmitt-Gräff, Stephan Ehl, Ursula J Buchholz, Peter L Collins, Peter Staeheli, Christine D Krempl.   

Abstract

Infection of mice with pneumonia virus of mice (PVM) provides a convenient experimental pathogenesis model in a natural host for a human respiratory syncytial virus-related virus. Extending our previous work showing that the PVM nonstructural (NS) proteins were pathogenicity factors in mice, we identify both the NS1 and NS2 proteins as antagonists of alpha/beta interferon (IFN-α/β) and IFN-λ by use of recombinant PVM (rPVM) with single and combined deletions of the NS proteinsNS1, ΔNS2, and ΔNS1 ΔNS2). Wild-type and NS deletion PVMs were evaluated for growth and pathogenesis by infecting knockout mice that lack functional receptors to IFN-α/β, IFN-λ, or both. The absence of the receptor to IFN-α/β (IFNAR) or IFN-λ (interleukin-28 receptor α chain [IL-28Rα]) individually did not reverse the attenuated virulence of the NS deletion viruses although loss of IFNAR partially restored replication efficiency. When both receptors were deleted, replication and virulence were largely rescued for rPVM ΔNS1 and were significantly but not completely rescued for rPVM ΔNS2. As for rPVM ΔNS1 ΔNS2, the effect was mostly limited to partial enhancement of replication. This indicates that both IFN-α/β and IFN-λ contributed to restricting the NS deletion viruses, with the former playing the greater role. Interestingly, the replication and virulence of wild-type PVM were completely unaffected by the presence or absence of functional receptors to IFN-α/β and IFN-λ, indicating that both systems are strongly suppressed during infection. However, pretreatment of mice with IFN-α/β was protective against lethal rPVM challenge, whereas pretreatment with IFN-λ delayed but did not prevent disease and, in some cases, reduced mortality. The fact that virulence of rPVM lacking NS2 was not recovered completely when both interferon receptors were deleted suggests that NS2 may have further functions outside the IFN system.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21307191      PMCID: PMC3126227          DOI: 10.1128/JVI.01365-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

1.  IL-28, IL-29 and their class II cytokine receptor IL-28R.

Authors:  Paul Sheppard; Wayne Kindsvogel; Wenfeng Xu; Katherine Henderson; Stacy Schlutsmeyer; Theodore E Whitmore; Rolf Kuestner; Ursula Garrigues; Carl Birks; Jenny Roraback; Craig Ostrander; Dennis Dong; Jinu Shin; Scott Presnell; Brian Fox; Betty Haldeman; Emily Cooper; David Taft; Teresa Gilbert; Francis J Grant; Monica Tackett; William Krivan; Gary McKnight; Chris Clegg; Don Foster; Kevin M Klucher
Journal:  Nat Immunol       Date:  2002-12-02       Impact factor: 25.606

2.  Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase.

Authors:  Joanne Elliott; Oonagh T Lynch; Yvonne Suessmuth; Ping Qian; Caroline R Boyd; James F Burrows; Richard Buick; Nigel J Stevenson; Olivier Touzelet; Massimo Gadina; Ultan F Power; James A Johnston
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

3.  Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction.

Authors:  Murali Ramaswamy; Lei Shi; Steven M Varga; Sailen Barik; Mark A Behlke; Dwight C Look
Journal:  Virology       Date:  2005-10-10       Impact factor: 3.616

4.  Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees.

Authors:  M N Teng; S S Whitehead; A Bermingham; M St Claire; W R Elkins; B R Murphy; P L Collins
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

5.  The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans.

Authors:  Peter F Wright; Ruth A Karron; Shabir A Madhi; John J Treanor; James C King; Alice O'Shea; Mine R Ikizler; Yuwei Zhu; Peter L Collins; Clare Cutland; Valerie B Randolph; Anne M Deatly; Jill G Hackell; William C Gruber; Brian R Murphy
Journal:  J Infect Dis       Date:  2006-01-19       Impact factor: 5.226

6.  Complete sequence of the RNA genome of pneumonia virus of mice (PVM).

Authors:  Christine D Krempl; Elaine W Lamirande; Peter L Collins
Journal:  Virus Genes       Date:  2005-03       Impact factor: 2.332

7.  Characterization of the murine alpha interferon gene family.

Authors:  Vincent van Pesch; Hanane Lanaya; Jean-Christophe Renauld; Thomas Michiels
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

8.  Deletion of nonstructural proteins NS1 and NS2 from pneumonia virus of mice attenuates viral replication and reduces pulmonary cytokine expression and disease.

Authors:  Ursula J Buchholz; Jerrold M Ward; Elaine W Lamirande; Britta Heinze; Christine D Krempl; Peter L Collins
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

9.  Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins.

Authors:  Jean-Francois Valarcher; Julie Furze; Sara Wyld; Roy Cook; Karl-Klaus Conzelmann; Geraldine Taylor
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

10.  Effect of exogenous interferon on rubella virus production in carrier cultures of cells defective in interferon production.

Authors:  K Mifune; J Desmyter; W E Rawls
Journal:  Infect Immun       Date:  1970-08       Impact factor: 3.441

View more
  18 in total

1.  Plasmacytoid dendritic cells promote host defense against acute pneumovirus infection via the TLR7-MyD88-dependent signaling pathway.

Authors:  Sophia Davidson; Gerard Kaiko; Zhixuan Loh; Amit Lalwani; Vivian Zhang; Kirsten Spann; Shen Yun Foo; Nicole Hansbro; Satoshi Uematsu; Shizuo Akira; Klaus I Matthaei; Helene F Rosenberg; Paul S Foster; Simon Phipps
Journal:  J Immunol       Date:  2011-04-11       Impact factor: 5.422

2.  Evaluation of pneumonia virus of mice as a possible human pathogen.

Authors:  Linda G Brock; Ruth A Karron; Christine D Krempl; Peter L Collins; Ursula J Buchholz
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

3.  The respiratory syncytial virus (RSV) nonstructural proteins mediate RSV suppression of glucocorticoid receptor transactivation.

Authors:  Jeanette I Webster Marketon; Jacqueline Corry; Michael N Teng
Journal:  Virology       Date:  2013-11-26       Impact factor: 3.616

4.  Animal model of respiratory syncytial virus: CD8+ T cells cause a cytokine storm that is chemically tractable by sphingosine-1-phosphate 1 receptor agonist therapy.

Authors:  Kevin B Walsh; John R Teijaro; Linda G Brock; Daniel M Fremgen; Peter L Collins; Hugh Rosen; Michael B A Oldstone
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

5.  Impact and regulation of lambda interferon response in human metapneumovirus infection.

Authors:  Ma Del Rocío Baños-Lara; Lindsey Harvey; Alexander Mendoza; Dawn Simms; Vladimir N Chouljenko; Nobuko Wakamatsu; K Gus Kousoulas; Antonieta Guerrero-Plata
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

6.  Sustained inflammation and differential expression of interferons type I and III in PVM-infected interferon-gamma (IFNγ) gene-deleted mice.

Authors:  Stephanie F Glineur; Aaron B Bowen; Caroline M Percopo; Katia E Garcia-Crespo; Kimberly D Dyer; Sergei I Ochkur; Nancy A Lee; James J Lee; Joseph B Domachowske; Helene F Rosenberg
Journal:  Virology       Date:  2014-08-28       Impact factor: 3.616

7.  Novel pneumoviruses (PnVs): Evolution and inflammatory pathology.

Authors:  Stephanie F Glineur; Randall W Renshaw; Caroline M Percopo; Kimberly D Dyer; Edward J Dubovi; Joseph B Domachowske; Helene F Rosenberg
Journal:  Virology       Date:  2013-06-10       Impact factor: 3.616

8.  IFN-λ exerts opposing effects on T cell responses depending on the chronicity of the virus infection.

Authors:  Ichiro Misumi; Jason K Whitmire
Journal:  J Immunol       Date:  2014-03-19       Impact factor: 5.422

9.  Pre-existing virus-specific CD8(+) T-cells provide protection against pneumovirus-induced disease in mice.

Authors:  Mary J G van Helden; Peter J S van Kooten; Cornelis P J Bekker; Andrea Gröne; David J Topham; Andrew J Easton; Claire J P Boog; Dirk H Busch; Dietmar M W Zaiss; Alice J A M Sijts
Journal:  Vaccine       Date:  2012-08-29       Impact factor: 3.641

10.  Rhinovirus Reduces the Severity of Subsequent Respiratory Viral Infections by Interferon-Dependent and -Independent Mechanisms.

Authors:  James T Van Leuven; Andres J Gonzalez; Emmanuel C Ijezie; Alexander Q Wixom; John L Clary; Maricris N Naranjo; Benjamin J Ridenhour; Craig R Miller; Tanya A Miura
Journal:  mSphere       Date:  2021-06-23       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.